Tudor Investment Corp’s Ascendis Pharma ASND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-21,299
| Closed | -$3.32M | – | 1557 |
|
|
2025
Q1 | $3.32M | Buy |
+21,299
| New | +$3.32M | 0.01% | 616 |
|
|
2024
Q4 | – | Sell |
-25,891
| Closed | -$3.87M | – | 1533 |
|
|
2024
Q3 | $3.87M | Sell |
25,891
-7,484
| -22% | -$1.12M | 0.01% | 528 |
|
|
2024
Q2 | $4.55M | Buy |
+33,375
| New | +$4.55M | 0.02% | 461 |
|
|
2023
Q4 | – | Sell |
-3,413
| Closed | -$320K | – | 1470 |
|
|
2023
Q3 | $320K | Buy |
+3,413
| New | +$320K | ﹤0.01% | 1234 |
|
|
2023
Q1 | – | Sell |
-27,476
| Closed | -$3.36M | – | 1548 |
|
|
2022
Q4 | $3.36M | Sell |
27,476
-4,456
| -14% | -$544K | 0.07% | 348 |
|
|
2022
Q3 | $3.3M | Buy |
31,932
+11,118
| +53% | +$1.15M | 0.07% | 337 |
|
|
2022
Q2 | $1.94M | Buy |
+20,814
| New | +$1.94M | 0.05% | 505 |
|
|
2021
Q3 | – | Sell |
-8,509
| Closed | -$1.12M | – | 1528 |
|
|
2021
Q2 | $1.12M | Sell |
8,509
-10,353
| -55% | -$1.36M | 0.02% | 771 |
|
|
2021
Q1 | $2.43M | Buy |
18,862
+5,990
| +47% | +$772K | 0.05% | 427 |
|
|
2020
Q4 | $2.15M | Buy |
12,872
+8,172
| +174% | +$1.36M | 0.06% | 390 |
|
|
2020
Q3 | $725K | Buy |
4,700
+1,575
| +50% | +$243K | 0.03% | 676 |
|
|
2020
Q2 | $462K | Buy |
+3,125
| New | +$462K | 0.02% | 747 |
|
|
2018
Q2 | – | Sell |
-11,705
| Closed | -$766K | – | 1021 |
|
|
2018
Q1 | $766K | Buy |
11,705
+4,195
| +56% | +$275K | 0.02% | 402 |
|
|
2017
Q4 | $301K | Buy |
7,510
+1,592
| +27% | +$63.8K | 0.01% | 793 |
|
|
2017
Q3 | $215K | Buy |
+5,918
| New | +$215K | 0.01% | 920 |
|